Fuller & Thaler Asset Management
IART icon

Fuller & Thaler Asset Management’s Integra LifeSciences IART Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$47.8M Sell
3,892,532
-29,987
-0.8% -$368K 0.17% 193
2025
Q1
$86.3M Sell
3,922,519
-9,760
-0.2% -$215K 0.34% 101
2024
Q4
$89.2M Sell
3,932,279
-35,283
-0.9% -$800K 0.34% 98
2024
Q3
$72.1M Buy
3,967,562
+2,125,647
+115% +$38.6M 0.28% 120
2024
Q2
$53.7M Buy
1,841,915
+1,401,045
+318% +$40.8M 0.23% 137
2024
Q1
$15.6M Sell
440,870
-400,189
-48% -$14.2M 0.07% 252
2023
Q4
$36.6M Buy
841,059
+235,565
+39% +$10.3M 0.19% 156
2023
Q3
$23.1M Sell
605,494
-56,669
-9% -$2.16M 0.13% 174
2023
Q2
$27.2M Sell
662,163
-847,220
-56% -$34.8M 0.15% 163
2023
Q1
$86.7M Sell
1,509,383
-3,269
-0.2% -$188K 0.5% 73
2022
Q4
$84.8M Buy
1,512,652
+713,454
+89% +$40M 0.54% 65
2022
Q3
$33.9M Sell
799,198
-556
-0.1% -$23.6K 0.24% 130
2022
Q2
$43.2M Sell
799,754
-2,970
-0.4% -$160K 0.3% 112
2022
Q1
$51.6M Buy
802,724
+98,702
+14% +$6.34M 0.31% 111
2021
Q4
$47.2M Buy
704,022
+109,220
+18% +$7.32M 0.27% 117
2021
Q3
$40.7M Buy
594,802
+294,052
+98% +$20.1M 0.26% 114
2021
Q2
$20.5M Buy
300,750
+14,554
+5% +$993K 0.13% 150
2021
Q1
$19.8M Buy
286,196
+1,651
+0.6% +$114K 0.14% 153
2020
Q4
$18.5M Buy
284,545
+206,260
+263% +$13.4M 0.17% 142
2020
Q3
$3.7M Buy
78,285
+242
+0.3% +$11.4K 0.05% 244
2020
Q2
$3.67M Sell
78,043
-67,422
-46% -$3.17M 0.05% 240
2020
Q1
$6.5M Buy
145,465
+968
+0.7% +$43.2K 0.11% 172
2019
Q4
$8.42M Buy
144,497
+1,395
+1% +$81.3K 0.09% 175
2019
Q3
$8.6M Buy
143,102
+31,449
+28% +$1.89M 0.1% 167
2019
Q2
$6.24M Buy
+111,653
New +$6.24M 0.07% 193